NovoCure Limited

Historical 13F Holders

Symbol
NVCR
CUSIP
G6674U108
All holders as of
Q2 2026
Type
Equity
Class
ORD SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for G6674U108 since 12/18/2024, largest first.

Filer % of Class Filed
Soleus Capital Master Fund, L.P. 13G/A
9.1% 5/8/2026
Event 3/31/2026
BlackRock, Inc. 13G/A 8.3% 4/23/2025
Event 3/31/2025
Vanguard Portfolio Management LLC 13G 5.6% 4/28/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Capital World Investors 13G/A 1.8% 11/13/2025
Event 9/30/2025
Capital International Investors 13G/A 0% 7/7/2025
Event 6/30/2025
Vanguard Group Inc 13G/A 0% 3/26/2026
Event 3/13/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 81 6.77 M $107 M
2026 Q2 219 105 M $1.69 B
2026 Q1 226 98.9 M $1.08 B
2025 Q4 241 95.7 M $1.24 B
2025 Q3 249 92.0 M $1.19 B
2025 Q2 248 94.5 M $1.68 B
2025 Q1 233 95.2 M $1.70 B
2024 Q4 246 91.7 M $2.73 B
2024 Q3 228 93.3 M $1.46 B
2024 Q2 240 93.9 M $1.61 B
2024 Q1 239 92.9 M $1.46 B
2023 Q4 224 92.4 M $1.38 B
2023 Q3 233 92.3 M $1.49 B
2023 Q2 270 90.9 M $3.78 B
2023 Q1 302 105 M $6.33 B
2022 Q4 319 87.3 M $6.41 B
2022 Q3 312 83.7 M $6.36 B
2022 Q2 325 80.8 M $5.65 B
2022 Q1 317 81.7 M $6.81 B
2021 Q4 319 79.2 M $5.95 B
2021 Q3 326 77.6 M $9.02 B
2021 Q2 367 77.8 M $17.2 B
2021 Q1 331 75.3 M $9.95 B
2020 Q4 362 74.8 M $13.0 B
2020 Q3 290 73.3 M $8.16 B
2020 Q2 266 69.2 M $4.10 B
2020 Q1 274 70.6 M $4.75 B
2019 Q4 264 70.2 M $5.90 B
2019 Q3 243 66.9 M $5.00 B
2019 Q2 200 68.8 M $4.35 B
2019 Q1 203 63.6 M $3.06 B
2018 Q4 169 57.8 M $1.94 B
2018 Q3 182 56.2 M $2.94 B
2018 Q2 166 52.1 M $1.63 B
2018 Q1 133 44.1 M $962 M
2017 Q4 130 37.4 M $756 M
2017 Q3 108 36.8 M $731 M
2017 Q2 90 31.9 M $552 M
2017 Q1 73 20.3 M $165 M
2016 Q4 79 20.5 M $161 M
2016 Q3 67 19.6 M $167 M
2016 Q2 68 19.5 M $228 M
2016 Q1 60 13.6 M $197 M
2015 Q4 48 11.7 M $257 M